chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Circle turned into darker, like a bruise at the injection site, still ongoing; swelled up; redness from her shoulder up to her right fingers; appeared a 1/4 red circle that lasted for 5 days, / Circle turned into darker, like a bruise at the injection site, still ongoing; hot from her shoulder up to her right fingers; sore right arm; felt tired; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (hot from her shoulder up to her right fingers), VACCINATION SITE BRUISING (Circle turned into darker, like a bruise at the injection site, still ongoing), SWELLING (swelled up), ERYTHEMA (redness from her shoulder up to her right fingers) and VACCINATION SITE ERYTHEMA (appeared a 1/4 red circle that lasted for 5 days, / Circle turned into darker, like a bruise at the injection site, still ongoing) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter. .  Concomitant products included supplements, ASCORBIC ACID, ROSA CANINA FRUIT (VITAMIN C & ROSEHIP) and ETHINYLESTRADIOL, FERROUS FUMARATE, NORETHISTERONE ACETATE (LO LOESTRIN FE) for an unknown indication.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, the patient experienced MYALGIA (sore right arm) and FATIGUE (felt tired). On 05-Feb-2021, the patient experienced FEELING HOT (hot from her shoulder up to her right fingers), SWELLING (swelled up), ERYTHEMA (redness from her shoulder up to her right fingers) and VACCINATION SITE ERYTHEMA (appeared a 1/4 red circle that lasted for 5 days, / Circle turned into darker, like a bruise at the injection site, still ongoing). On an unknown date, the patient experienced VACCINATION SITE BRUISING (Circle turned into darker, like a bruise at the injection site, still ongoing). On 30-Jan-2021, FATIGUE (felt tired) had resolved. On 01-Feb-2021, MYALGIA (sore right arm) had resolved. On 07-Feb-2021, SWELLING (swelled up) had resolved. At the time of the report, FEELING HOT (hot from her shoulder up to her right fingers), ERYTHEMA (redness from her shoulder up to her right fingers) and VACCINATION SITE ERYTHEMA (appeared a 1/4 red circle that lasted for 5 days, / Circle turned into darker, like a bruise at the injection site, still ongoing) had not resolved and VACCINATION SITE BRUISING (Circle turned into darker, like a bruise at the injection site, still ongoing) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient use ice in injection site.
Hives, Itching on left arm, and both legs.  Stated the left leg was worse.  He took Benedryl and it resolved.
Headache, Arthralgia, Diarrhea, NauseaVomiting, extreme fatigue Narrative:
she has been diagnosed with a GI infection and is currently experiencing bloody stools.; she has been diagnosed with a GI infection and is currently experiencing bloody stools.; she got sick; I have been having joint pain ever since I got the first dose and don't feel like maybe should take it today.; This is a spontaneous report received from a contactable consumer (patient) via a Pfizer sponsored program and also via Medical Information Team. A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection; Lot number and expiration date was not reported), via an unspecified route of administration, on 31Mar2021 as single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient reported that she had her first dose of Pfizer Covid-19 vaccine on 31Mar2021 and was scheduled to take her second dose on 26Apr2021. On an unspecified date in 2021, she got sick and was admitted at the ER and was told that she has an inflammation and infection in her intestine/colon. She was diagnosed with GI infection and experiencing bloody stools at the time of the report. She also reported that she was having joint pain ever since she got the first dose and did not feel like taking the vaccine. The outcome of the events was unknown.   Information about Lot/Batch number has been requested.
Patient with PMH for Parkinson's disease presented to ED with chest pain and SOB.  Patient was diagnosed with Covid-19 on 11/04/2021 with symptoms starting two days prior.  Patient was treated with monoclonal AB and doxycycline and CTA at the time was negative for PE.  He returned home that day and returned on 11/19/2021 from his PCP office with PNA and weight loss, he was found to have a small right apical pneumothorax and opted to return home with repeat CXR on 11/22/2021 as outpatient which showed no change in pneumo size.  He returned to ED on 11/25/2021 with CP and worsened by exertion and deep breathing.  Also had cough with productive sputum and dyspnea.  CT showed lower lobe PE with mild flattening of intraventricular septum, multifocal PNA, small bilateral pneumothoraxes, and pneumomediastinum.  Patient was admitted to ICU for acute hypoxemic respiratory failure requiring high levels of Oxygen, and noted to be in Afib with RVR.  Patient family decided to patient patient comfort measures.  Patient expired on 12/09/2021.
Child was at County Health Department to receive immunizations. Was brought to my attention recently at an appointment with a doctor (not at same facility)  that the 2nd MMR shot had been administered to her by mistake. Health Department looked into situation, found it not to be a clerical error, apologized for mistake. Would now like them to have a titers blood test administered to check her and know for certain that we can safely proceed with further vaccinations. Health Department uncooperative. Also they assured me that it was fine that she had received the MMR early but were unsure of whether or not she would require another. I was not notified of the mistake through them. Why can a public health organization make a mistake of actually insterting a child with the wrong vaccine, not catch the mistake, and now not be responsible to do everything possible to be sure it is safe for her to continue with her immunization schedule?
I woke up with my right eye blood shot and thought it was a simple broken blood vessel. The next day the blood shot had spread in the right eye and my eye felt "sore", like a sore muscle. I saw the eye doctor that same day and was diagnosed with Iritis. I have never had Iritis and I have no history personally or in my family of any chronic autoimmune disease.
Pt reported feeling dizziness, lightheaded, near syncope, numbness/tingling up neck into chest area, numbness and tingling in extremities. Feeling of impending doom, chest pressure with SOB. Pt was given Epi-Pen 0.3mg in clinic, transported via EMS to local ER at which time 50IV Benadryl given while in Ambulance, and  4mg decadron in ER. Pt was discharged from ER at 3:00pm
Per MOC, noted Redness to outer aspect of Left arm (upper) when pt woke morning after he got vaccines
At 1:32pm Clinical Pharmacist alerted Nurse that patient verbalized that she was feeling dizzy, nauseous, "tingling on my face" and pain in the arm. RN responded and took the vitals signs recorded above. Patient reported last food eaten was at 10am. She came to the vaccine appointment from work. She reported she had not had much fluid to drink today. RN provided a cup of water (about 240mL). Patient has a history of anxiety and depression. Patient reports that she takes Hydroxyzine for anxiety in emergencies. She also takes Zoloft for depression. Patient denies any history of diabetes and heart conditions. Patient reports that she has an inhaler that she has not used recently. She reports she uses it for "when she overheats". Patient denies chest or throat tightness. Presented patient to NP. Agreed with plan for patient to wait in observation station until patient felt comfortable returning home. Coached patient in deep breathing exercises and advised patient on signs of more severe reactions and when to be seen at an Emergency room. Patient agreed to plan and verbalized a second time that she had no chest or throat tightness. Patient left at 2:02pm.
Pt was given 0.25ml of flu vaccine on 12/06/04. Reaction began 12/7/04. Red blotches from waist down on 12/8/04. Progressed to entire body by 12/9/04. Benadryl was started on 12/8/04. On 12/9/04, child went to med ctr and started Atarax.
Initial information received on 08-Mar-2019 regarding an unsolicited valid non-serious case received from other health professional. This case involves patient of an unknown demographics who experienced tenderness, while he/she received vaccine DIPHTHERIA, TETANUS AND ACELLULAR PERTUSSIS VACCINE. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received a dose of suspect DIPHTHERIA, TETANUS AND ACELLULAR PERTUSSIS VACCINE produced by unknown manufacturer lot number not reported via unknown route in unknown administration site. On an unknown date, the patient developed a non-serious tenderness following the administration of DIPHTHERIA and TETANUS AND ACELLULAR PERTUSSIS VACCINE. (Other relevant tests included no lab data.). Final diagnosis was tenderness. It was not reported if the patient received a corrective treatment. The patient outcome is reported as Unknown for tenderness. Documents held by sender: none.
AUG96 pt broke out w/hives p/eating bread, cheese or any product w/yeast;to MD given med;
Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Additional Details: Patient experienced swollen, red, itchy, hot, sore arm around injection site 2 days after injection. Another pharmacist suggested going to Emergency Room and site was confirmed as infected
Patient reports minor pain day of shot which became progressively worse over the following days. Pain is sharp and radiates upwards.
he didn't sleep well; pain in arm; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (he didn't sleep well) and PAIN IN EXTREMITY (pain in arm) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025L20A and 010M20A) for COVID-19 vaccination.     No Medical History Information was reported.  Concomitant products included HYDROCHLOROTHIAZIDE, CARVEDILOL, LISINOPRIL, ATORVASTATIN and METFORMIN for an unknown indication.   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Feb-2021, the patient experienced INSOMNIA (he didn't sleep well) and PAIN IN EXTREMITY (pain in arm). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, INSOMNIA (he didn't sleep well) and PAIN IN EXTREMITY (pain in arm) outcome was unknown.
The day after injection (Wednesday), pt stated she had swelling the size of a softball at injection site, redness, slight itching. She took Tylenol prn for discomfort. Symptoms resolved by monday
This case was reported by a physician via call center representative and described the occurrence of extensive swelling of vaccinated limb in a adult patient who received Influenza vaccine Quadrivalent for prophylaxis. On 9th October 2018 10:00, the patient received Influenza vaccine Quadrivalent 2018-2019 season (intramuscular). On 9th October 2018, less than a day after receiving Influenza vaccine Quadrivalent 2018-2019 season, the patient experienced extensive swelling of vaccinated limb and injection site itching. On an unknown date, the outcome of the extensive swelling of vaccinated limb and injection site itching were unknown. It was unknown if the reporter considered the extensive swelling of vaccinated limb and injection site itching to be related to Influenza vaccine Quadrivalent 2018-2019 season. Additional details were provided as follows: The age at vaccination was not reported. After receiving Flu vaccine, the patient experienced itching and swelling over an 8 cm by 8 cm by 3 cm area at the injection. The reporter knew it was a GSK product but was unable to provide the name or any other information at the time of the call. The staff member would call back to provide additional information. This case was transferred to medical information. This case has been linked with the case US2018183707, US2018183712 and US2018GSK186850 reported by same reporter.
passed out; feeling dizzy; fell out of his chair on to the ground; B/P 136/90; BGL 148; feeling nauseous; tingly feeling in arm and chest; This is a spontaneous report from a contactable Hcp. A 24-years-old male patient received bnt162b2 (BNT162B2), dose 1 intramuscular on 31May2021 11:45 (Lot Number: EW0171) at 24-years-old as 1st dose, single for covid-19 immunisation.  The patient medical history was not reported. The patient's concomitant medications were not reported.  On 31May2021, the patient waiting in observation and started feeling dizzy then passed out and fell out of his chair on to the ground. Obtained baseline vitals B/P 136/90, BGL 148, O2 96% pulse 69 PT was alert immediately after falling we gave water and observed further got another set of vitals B/P 120/78 02 started feeling nauseous and called 911. overall felt nauseous and tingly feeling in arm and chest no pain, and passed out. The patient received first aid for events. The outcome of events was recovered on 31May2021.; Sender's Comments: Based on known drug safety profile, there is reasonable possibility of causal association between the events Loss of consciousness, Dizziness, Fall, Blood pressure increased, Blood glucose increased, Nausea, Paraesthesia and the suspect drug BNT162B2. Based on known drug safety profile, there is reasonable possibility of causal association between the event Loss of consciousness, Dizziness, Fall, Blood pressure increased, Blood glucose increased, Nausea and Paresthesia the suspect drug BNT162B2. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Severe muscle deconditioning Patient is a very pleasant 84 y.o. male patient of MD with history of alcohol abuse, CAD, COPD, depression, DM2 and HTN, mild dementia presented to Hospital with c/o shortness of breath on 11/7/2022.  The patient was experiencing acute hypoxemic respiratory failure from multiple etiologies including acute exacerbation of COPD, acute bronchitis, and COVID-19 positive pneumonia.  Patient was seen in consultation by infectious disease and the patient did receive remdesivir and IV dexamethasone and has improved significantly however due to his prolonged hospitalization the patient is significantly debilitated with severe muscle deconditioning and after a comprehensive evaluation by both physical and occupational therapies the patient has been deemed to be an appropriate candidate for aggressive rehabilitation here at transitional care unit.  This morning on physical exam the patient is examined at bedside he is awake alert and oriented x3 and denies any new complaints and specifically denies any chest pain or worsening shortness of breath, nausea or vomiting, diarrhea or constipation, dizziness or headache.  He will begin his aggressive rehabilitation plan of care soon as possible.   11/22/22:  Has delirium and he has history of confusion due to previous alcohol use is underlying mood disorder versus encephalopathy from alcohol withdrawal versus dementia due to alcoholism versus early dementia    Acute hypoxemic respiratory failure  Due to multiple etiologies including acute exacerbation of COPD, acute bronchitis and COVID-19 pneumonia.  Patient was treated aggressively with remdesivir and IV dexamethasone and now remains on supplemental oxygen at 3 L/min per nasal cannula but denies any worsening shortness of breath.  We will continue with nebulized bronchodilators and attempt to wean supplemental oxygen as tolerated. 11/22/22: He has COVID-19 he recovered from it but he has confusion x-ray is pending labs are unremarkable but the white count is borderline he will be treated with supportive care and antibiotic if needed    Hypertension Blood pressures are currently well controlled on atenolol 50 mg daily.   COPD (chronic obstructive pulmonary disease)  We will continue with nebulized bronchodilators and aggressive pulmonary hygiene. 11/22/22: He has COVID-19 he recovered from it but he has  abnormal x-ray  he will be treated with  antibiotic   Diabetes mellitus We will restart metformin and continue with sliding scale insulin as needed.  Most recent hemoglobin A1c was 7.0. 11/22/22: He has type 2 diabetes currently on metformin blood sugar has been good    Gastroesophageal reflux disease without esophagitis We will continue with Protonix 40 mg daily and as needed Maalox plus.   Alcoholism  Patient currently not exhibiting any signs of withdrawal will be encouraged abstinence upon discharge.
Pt developed acute abdominal pain - 2 hrs after injection of (1) GARDASIL; (2) MENACTRA, (3) TDAP. Pt was evaluated in ER - diagnosis acute UTI. 48 hrs later admission to hospital. Tx IV's and antibiotics.  6/15/09 Received hospital medical records for 3/27-3/28/2009 & ER records for 3/25/09. FINAL DX: Urinary tract infection, low back pain. Records reveal patient experienced abdominal pain, and fever. Seen in ER for UTI and discharged. Admitted for further evaluation of RLQ abdominal and R flank pain. Lightheadedness, nasal congestion and drainage, nausea and constipation. Costovertebral angle tenderness on the right. Muscle spasms. Neck pain.  7/9/09 ICD-9 codes received: 599.0, Y724.2, YV45.2, 789.00, 780.60
Information has been received from a healthcare worker referring to unspecified patient of unknown age and gender. No concurrent condition, concomitant therapies or medical history were reported. The reporter noted, that one unspecified patient was administered with improperly stored ZOSTAVAX (dose, route of administration and indication were unknown; Lot # K008885, an expiration date 20-SEP-2015) on 27-APR-2015. There was no adverse effect reported. This is one of the several reports received from the same reporter. Additional information has been requested.
The initial case was missing the following minimum criteria: no adverse effect (unspecified). Upon receipt of follow-up information on 27Jul2021, this case now contains all required information to be considered valid. This is a spontaneous report from the contactable consumers (including patient's wife) and physician. A 69-year-old male patient received pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) (PNEUMOCOCCAL 13-VAL CONJ VAC (DIPHT CRM197 PROTEIN)), in Feb2012 (Batch/Lot Number: EN6198) as DOSE 1, SINGLE, and on 03Mar2021 17:45 (Batch/Lot number was not reported) as DOSE 2, SINGLE both given via an unspecified route of administration for COVID-19 and cefalexin (KEFLEX), via an unspecified route of administration from 10Mar2021 (Batch/Lot number was not reported) to 10Mar2021, at unspecified dose and for an unspecified indication. Medical history and concomitant medications were not reported. The patient had pneumonia vaccine in Feb2012 and he ended up in hospital because he had a reaction (unspecified) from it. On 03Mar2021 17:45, the patient had the 2nd dose of pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) for COVID 19 (as reported- pending clarification). It was also mentioned that the patient had COVID vaccines, the first was 10Feb2021 and the second was on 03Mar2021 at 6pm (AER 2021311937). It was reported that on 05Mar2021 the patient had a small cut patient procedure done to remove lymph node under left arm (noted on unknown date). On 10Mar2021, the surgeon put the patient on cefalexin. Half hour after taking cefalexin, the patient started seizing, then vomiting uncontrollably. The patient was rushed to hospital by ambulance/emergency room and was admitted on 10Mar2021. The patient had numerous labs including chest X-ray, chest CT scan, brain MRI, and lumbar puncture in 2021 with unknown results. The patient was then discharged on 13Mar2021. Outcome of the events were unknown.
On January 19, one week after I got the vaccine, the area of vaccination got swollen, red, and was in pain. I took ibuprofen and used an ice pack to bring down the swelling. On January 20, the swelling got down but there is still redness and slight pain when I lift my arm. I will call my primary care doctor today to get more information.
PLEPHAROSPASMS - RAPID BLINKING AND EXTRAOCULAR MUSCLE DYSFUNCTION WITH INABILITY TO FOCUS EYES IN DIRECTION OF GAZE.
This spontaneous report as received from a other health professional refers to a patient of unknown age. On 21-AUG-2017, the patient was vaccinated with ROTATEQ lot # L027719, 1 DF, oral for prophylaxis. On 21-AUG-2017, the patient experienced expired product administered. On an unknown date, the patient experienced no adverse event. The outcome of expired product administered and no adverse event was unknown. The reporter considered expired product administered and no adverse event to be not related to ROTATEQ.
Approximately 8 hours after vaccines given in clinic, patient developed right-sided arm shaking, eyes rolling in back of head, concern for seizure activity. EMS was called, patient evaluated at Emergency room. Diagnosed with febrile seizures (history of tactile temps at home to 105), but afebrile to 37.2 in our ER during his ED visit.  No further workup, discharged with diagnosis of "Febrile seizure".
1 minute after administration of vaccine patient experienced warm ness and lightheaded and a little dizzy. She was extremely anxious about receiving the shot prior to.  I asked her to breath and relax and I fanned her. After about 10 minutes she felt better
But yesterday, caller hurt her back, although this is a condition that comes up every now and then; This is a spontaneous report from a contactable Consumer (Patient). A female patient of unknown age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number and Expiration date were not Provided) via unspecified route of administration on 06Feb2021 at single dose for covid-19 vaccination. Medical history included back condition the flares up when she picks up heavy items, that she treats with Oxycodone. concomitant medications were not reported.   The reporter (the patient) stated that she had the COVID shot on Saturday, and she was told at the time to take Tylenol if needed, instead of other pain killers and not to take Advil. had no adverse effects. On 08Feb2021, the patient hurt her back, although this is a condition that comes up every now and then, and the patient usually just takes one Oxycodone and the pain goes away, was afraid to take the Oxycodone without knowing if it will effect the vaccine. The patient queried about use of antipyretics before or after vaccination with the Pfizer-BioNTech COVID-19 vaccine, whether oxycodone will affect her vaccine. The patient confirms that her issues with her back have occurred many times prior to getting the COVID shot, many times over the years. The patient was picking up cartons yesterday and caused it. Investigation Assessment was not Provided. Outcome of the event was unknown.  Information on the lot/batch number has been requested.